Peter Briger: Helping Bring Fortress to New Levels

Peter Briger is the Co-Chairman for the Fortress Investment group and has been so since 2009. He began his stint at the company during 2006 before being promoted to Co-Chairman. Briger is in charge of both Fortress Investment Group’s credit and real estate activities. The Fortress Investment Group has recently been acquired by SoftBank. SoftBank is a Japanese company that holds the title of being one of the world’s largest investment companies. With it’s acquisition of Fortress Investment Group, SoftBank rises closer towards being the top investment company in the world. Peter Briger and his other two co-chairman for Fortress Investment Group are bringing in a hefty one billion dollars each due to the 3.3 billion dollar acquisition.

Fortress Investment Group will continue to run as it always has. Peter Briger and the other chairman will still have nearly all say in the day to day activities of the company. When asked, the CEO of Fortress stated that the chairmen and top management positions were completely fine with the face that they are now removed from the NYSE and that they are all excited to work as a private and independent company despite the acquisition. SoftBank -The company that acquired Fortress- has over forty years of experience and was established in 1981. The company is invested in over four hundred different Internet-based businesses and continues to grow. It began to evolve and grow exponentially after investing in Yahoo! during it’s peak as an internet business.

Fortress on the other hand is a bit newer. The company has only been around roughly half as long as SoftBank. However, with the combined efforts of Peter Briger and the other top members of the company, the Fortress Investment Group has grown to manage the investments of nearly 2000 different clients. It was an odd decision for SoftBank to invest such a large amount into a company that it will not have much say in how it operates. However, it was an intelligent move. SoftBank specializes in the acquiring of internet businesses. They’re not a specialized investment group. By acquiring an investment company as large as Fortress, SoftBank gives itself key resources for branching into the world of investing. On the other side of the equation, Fortress is now a private company. It’s not publically traded anymore. They also gain access to dozens of Asian companies as resources and partners. So, in the end it’s a double win. Both companies benefit greatly and neither of them sacrifice any control over their company.

Jeff Aronin and Paragon Biosciences: No illness is to small

Jeff Aronin is the CEO of Paragon Biosciences, a company that starts, invests, supports and nurtures Biotechnology companies that focus their research on obscure illnesses and rare diseases that may not get a lot of attention do to the amount of affected patients, difficulty or lack of a cure or treatment.


Instead of concentrating on medicines and treatments that may not address the true cause of the disease, Jeff Aronin is helping to usher in a time of innovative thinking in regards to how we view and treat the illnesses that we don’t understand or know how to treat. By building companies that support new techniques in research, Pharmaceuticals, and education he has ensured a wider range of treatment giving patients hope for real cures, and a better way of life.


Biotechnical research is not Jeff Aronin’s only way of helping others. He is an active philanthropist. Both home and abroad, he helps such organizations as the Cystic Fibrosis Foundation, Juvenile Diabetes Research Foundation, Susan G. Komen Breast Cancer Organization, Friends of Israel Defense Forces, US Holocaust Museum, the Jewish National Fund, and Boys and Girls Club of Chicago, just to name a few.


By helping the medical, pharmaceutical, and bioscience fields, Jeff Aronin is providing a well rounded and groundbreaking approach to medical problems both big and small.


Under Jeff Aronin’s leadership, some of the companies associated with Paragon Biosciences have cleared 13 different medications through the FDA in the last 10 years. Paragon Biosciences uses this strategy: understand, identify, build. First understand the illness, then identify the science needed to address the illness, and build the companies that can get the proper medicine approved and to the patients that will benefit the most.


Because of this strategy and the belief in helping the people that need it most, Jeff Aronin and Paragon Biosciences have made a significant difference with pharmaceuticals, rare diseases, and the science that connects them.


Marc Beer Of Renovia Holds Successful Series B Funding Round

Marc Beer has been in the pharmaceuticals business for more than 25 years. He is one of the co-founders of Renovia Inc. and is its chairman of the board and chief executive officer. His company is a startup that develops devices to treat pelvic floor disorders in women. He has worked for a number of other firms in the pharmaceutical industry in the past such as ViaCell, Genzyme, and Good Start Genetics, Inc. He is a graduate of Miami University which is in Oxford, Ohio.

Renovia recently held its Series B funding round. Marc Beer says that they were able to raise $32 million from this and also brought in another $10 million in the form of venture debt. He is planning on using this money to develop and test additional devices for the treatment of pelvic floor disorder as well as improve the device they now have on the market. There are three main types of this disorder which are a lack of bowel control, urinary incontinence, and pelvic organ prolapse. These disorders are caused by the bowel, bladder, and/or uterus “dropping” down onto the vagina and thus causing complications.

Marc Beer says that around 250 million in the world are afflicted by pelvic drop disorders. His company’s first product, Leva, was approved for use in the United States by the FDA in April 2018. Leva is a device that helps women train their pelvic muscles so that they become stronger. This device can help women avoid surgery and/or being on medications to treat their condition.

There were a few venture capital firms interested in investing in Renovia during its Series B round. Among these were Perceptive Advisors, Longwood Fund, and Ascension Ventures. Talking about this round of funding, Marc Beer said that he was very happy that some of the nation’s leading healthcare investors were interested in his company’s mission to improve the lives of millions of women around the world. He added that the money would also be used to improve their digital health platform which provides women with valuable data about their condition and the treatment options that exist for it.

During the course of his career, Marc Beer has been on a number of advisory boards. He has been on his alma mater’s Business Advisory Council and was once on the Research and Commercialization Advisory Committee for Notre Dame. He has also worked as a strategic consultant for other firms such as OvaScience. Learn more :

Dr. Eric Forsthoefel Talks About The Crisis Of Emergency Room Overcrowding In America

A major problem facing the healthcare industry today is the tendency for Americans to travel to the nearest emergency room to address common conditions that do not demand urgent care. Dr. Eric Forsthoefel has many spent the entirety of his career working in emergency rooms and trauma centers. This experience has provided him with firsthand knowledge of how the overuse of these facilities for non-urgent health care needs have overburdened these facilities to the point that they are sometimes unable to adequately provide service to those that need them.

Dr. Forsthoefel explains in a recent interview that many patients turn to emergency rooms for routine health care due to the lack of access to primary care that has become a problem for many Americans. Forsthoefel goes on to explain that each patient arriving at local emergency rooms or trauma centers is met with the best efforts of emergency room staff regardless of the nature of the illness or injury that prompted their arrivals. This can be problematic Forsthoefel says because resources sometimes are stretched to the point that it becomes a challenge to pay adequate attention to the truly critical patients that are in need of emergency services.

Dr. Forsthoefel reiterated before ending the interview that all patients entering emergency facilities are treated with the best care possible and says emergency room personnel is sympathetic to the fact that many face barriers that make other treatment options unavailable to them. The fact remains however that many of the resources intended for acute and emergency patients are being diverted more and more towards patients with non-urgent needs.

The opinions of Dr. Eric Forsthoefel and other doctors working in emergency rooms is supported by the present data. A survey done by Harris in 2005, asked emergency room physicians to provide the top reasons they believe people overuse emergency room services. Doctors expressed time and time again that the wait time that is necessary when a patient makes an appointment with a primary care physician is a primary factor in the overcrowding of local emergency rooms and trauma centers in America. The physicians also said the problem becomes considerably worse at nights and on weekends because many primary care clinics are not open for business at these times.

The conclusion drawn by Dr. Forsthoefel and other emergency room physicians is that primary care physicians can do a great deal to lessen the burden on emergency rooms across the country by offering greater access to patient services on nights and weekends.

About Eric Forsthoefel

Dr. Eric Forsthoefel is an emergency room physician that has served the people of Tallahassee Florida for the past seven years. Forsthoefel attended the School of Medicine at Louisiana State University and completed the requirements for his degree in 2011.

Paul Mampilly making the future of investors brighter through effective strategies

Eric Dye, the host of the famous entrepreneur podcast network always takes time to evaluate who he is bringing on air and this time his listeners were even more fortunate as he interviewed, Paul Mampilly, a prominent financial analyst who is also the force behind profits unlimited.

Paul Mampilly and Eric discussed various matters affecting the world of finance thus giving listeners a dose of how to excel in this highly competitive sector. For instance, Paul urged listeners not to make the mistake that most new investors make such as investing all they have on a single stock. In other words, Paul calls traders to diversify their portfolio to spread risks and maximize their profits. He also urged them to take advantage of the times when the market is shaky because then, stocks are often at their lowest price.

Paul Mampilly also talked about the difference in our market today and twenty years ago. According to him, average investors have to work two times harder in choosing stocks because unlike twenty years ago, mutual funds are no longer dominant thus making ETF’s the driving force of the stock market.

Paul is renowned for his useful stock advice. Every strategy he has ever offered, every stock suggestion that he has ever made to his profits unlimited newsletter has always proven to be effective. When asked what the secret behind his useful stock insight is, Paul Mampilly revealed that he dedicates about twelve to thirteen hours every day researching and following stocks his clients purchase to see whether they’ll bring them profits in the long run. He also analyzes different companies in the stock exchange and comes up with those he deems best and also considers factors that may affect prices and then updates his subscribers with all the details. Paul Mampilly Has Struck Gold Again.

As humans, we all have that one individual whom we look up to and Paul Mampilly is no exception. During the interview, he revealed that he admires Elon Musk, Founder of Tesla for his proactive nature and the fact that he spearheaded the manufacture of electric cars even before people could consider them.

To learn more visit: here.

A Brief History in Beauty: The Evolution of EOS Lip Balm

At first there was only a spark of imagination revolving around lip care that would forever change the landscape of the beauty section. A massive amount of research went into developing EOS lip balms, and co-founders Jonathan Teller and Sajiv Mehra set out to conduct market studies. What they found was that lip balms had primarily been purchased by women, but were marketed for both sexes in an extremely dull fashion. They also found that searching in a ladies purse for her lip balm can be very difficult, and also using tins or jars that would require dipping in your finger for application ultimately makes a big mess. Teller and Mehra recognized this significant gap in the market, and the creation of the smooth, round, and hands-free, design of the EOS lip balm had begun. Walgreens was the first company to launch the product, and after a successful run of sales, big box stores, and even companies in other countries, were knocking at the door looking for partnerships. Because of this spike in growth, EOS had to turn down business with some prospects so that they could develop their own manufacturing facility. Marketing also played huge role in elevating the brands’ popularity. With the rising use of social media, EOS started marketing their product through top influencers by matching products with people, and trickling down to followers. Miley Cyrus and Demi Lovato have contributed to this by premiering the lovely lip balms in their music videos. It’s no secret that woman of all ages have come to adore and covet EOS lip balms for its fun packaging, super moisturizing textures, and all natural ingredients, but there is more to come from this innovative company as they have launched a full skin care line, stretching beyond the boundaries of lip care.


CLAY B. SIEGALL has a Ph.D. in genetics which he obtained from George Washington University. He also has a Bachelor of Science, Zoology which he attained at the University of Maryland.

He is a co-founder of Seattle Genetics Company which he has built on a foundation of innovation, through drug development research processes with a firm resolve and motivation to help patients.

He is the company’s president, CEO and also the chairperson of the board. Dr. Siegall is a trained scientist and has put most of his efforts into cancer therapy.

Before co-founding Seattle Genetics, Dr. Siegall worked in the Bristol- Myers Squibb Pharmaceutical Research Institute between 1991 and 1997. He also worked at the National Cancer Institute between 1988 and 1991.

During Dr. Siegall’s time at the helm, Seattle Genetics has acquired many necessary licenses for its ADC technology including GlaxoSmithKline, Genentech, Pfizer, and AbbVie which have created more than $350 million.

There are more than 20 ADCs in clinical development that currently use Seattle Genetics technology across internal and collaborator programs. He has also led Seattle genetics’ capital raising endeavors generating more than $1.2 billion through various funding initiatives including the company’s initial public offering in 2001.

Dr. Siegall led the company in obtaining the 2011 FDA approval of its initial ADC product ADCETRIS which is now a worldwide brand that has been approved by more than 60 countries in partnership with Takeda pharmaceutical company.

Dr. Siegall is a member of the board of directors at Ultragenyx Pharmaceutical, Alder Biopharmaceuticals, and The Washington Roundtable. He has been the recipient of some accolades including the 2013 University of Maryland Alumnus of the year for Computer, Math and Natural sciences and the 2012 Pacific Northwest Ernst and Young Entrepreneur of the year award.

He has written more than 65 publications and also holds more than ten patents. Dr. Siegal’s motivation stems from his past experiences. For instance, the unfortunate experience of losing a father at the early age of 24 due to cancer motivated him to specialize in cancer therapy and treatment.

Venture Capitalist William Saito Rings the Alarm on Global Cybersecurity Laxity

William Saito, Japanese-American venture capitalist and one-time Special Advisor to the Japanese Cabinet Office, wrote an article on The Huffington Post detailing the importance of online privacy and security in an increasingly digitized world.


Saito began the article by noting the central and all-encompassing role the internet plays in daily modern life, compared to the strictly academic role it occupied for much of the 1960s, 70s and 80s. In analyzing the reasons behind this seismic shift, Saito credited the developments of the World Wide Web in 1989 and high-speed data transmission in the late 1990s with being responsible for making the internet as ubiquitous as it has become.

However, Saito also cited an important (albeit possibly “less viable“, in his opinion) reason for the modern-day popularity of the internet – the development of informational security. Saito points out that without security, the ability to not only engage personally on the internet, but to conduct business communications and carry out transactions is severely undercut.


Saito, in the article, expresses concerns that the integration of wireless capabilities into household items such as refrigerators, air conditioners and heaters is being carried out with little to no regard for the role security plays in making the internet safe for public use. He also cites the minimal concern that corporations and organizations pay to cybersecurity – as seen in the 2014 theft and leak of confidential materials from Sony Pictures.


Saito urges a collective reexamination of cybersecurity, with the aims of ensuring that both public and private sector outfits are protected. He highlights the World Economic Forum as a prime platform for such a reexamination to occur.


Read the full article here.


William Saito was born in Los Angeles, the child of Japanese immigrants. He is an alumni of the University of California, Riverside and has served as an adviser on cybersecurity to Japanese Prime Minister Shinzo Abe, as well as the Japanese Cabinet Office and the Ministry of Economy, Trade and Industry (METI). He has also served on advisory boards to major Japanese-based multinational corporations such as Japan Airlines, Fast Retailing and Hakuhodo.

A Triathlete Steps Up To Promote Herbalife And Herbalife24

In these days and times, it’s great to see athletes give back to the communities. With that being in the forefront, Heather Jackson is doing a wonderful job with giving love back to the communities. Currently, Jackson takes time out of a busy schedule to let children know that there are a hope and a place for new athletes to rise to the occasions. As a matter of fact, the triathlete reminds children that dreams start when in the youth prime.


Heather, born in Exeter, New Hampshire, is a world champion in soccer, cycling, and ice hockey. To put it in clearer terms, Heather Jackson has had a great career, and luckily, the star athlete has been recognized by Herbalife. Subsequently, the company wanted Heather to be a sponsored athlete, showcasing their products and services. Furthermore, Jackson promotes the nutritional supplement during the off-season. But when sports activities are taking place, Herbalife uses Heather to promote some of their other products as well.



Generally speaking, Herbalife is number one in the sales of natural supplements. Internationally driven, the company makes shakes, vitamins, capsules, weight management products, personal hygiene products, and sports nutritional capsules (2018). Believe it or not, the company has been around since 1980. And decades later, the business has grown to impact the world. In the light of the company, Herbalife seems to sell more of the shakes. Technically, it’s the easiest supplement to manage when having an on the go lifestyle. In fact, Herbalife24 offers additional supplements that can be taken with meals to support a client during strenuous life activities. With that being said, Herbalife appreciates Jackson’s support, and on top of that, the athlete is allowing sponsorship to take place for more products in the future. In conclusion, the athlete plans to continue to spread the great news about the company, but at the same time, Heather Jackson will continue to take the supplements while providing them for family and friends as well. As for Herbalife, the company is planning to continue cultivating new supplements that will assist toddlers.

Is Social Media Killing Art Appreciation? Ann Scango Weighs In

In a recent blog post, Austin artist Ann Scango speculates on the effect that the modern social media craze has had upon the world of art. She is joined in her ruminations by Jia Jia Fey, the former director of digital marketing for the Guggenheim Museum. They provide an interesting perspective on the changes in consciousness that have been wrought by our social media obsession.

Image result for contemporary art

In the past, when someone went to a museum there was a certain sense of anticipation. Before the invention of photography museum-goers would have had nothing to go on except word of mouth or maybe a rough sketch. Even long after the invention of photography it was impossible to get the full impact of a great work of art.


All of this has now changed. Thanks to the prevalent and sometimes annoying habit that people have of taking selfies everywhere, images have lost much of their impact. Ms. Fey explains to us that in the past, people just came to the art museum so that they could see great works of art and could say that they had seen them. But now, she says, it is just another excuse to take a selfie and spread the imagery all over the internet. In short, they have ruined the magic.


Ann Scango is a prominent Texan artist who specializes in creating textured works of art that are meant to reflect the inherent connection between humanity and nature. She has been making art and developing her distinctive style since she was very young. She likes to experiment with all sorts of different materials for the creation of her works. She uses industrial materials, carveable foam, and natural materials taken from nature. There is a very strong mosaic feel to her work as she weaves together many disparate threads to make some extremely thought provoking pieces.